S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
Laser breakthrough could send stock soaring 2,467% (Ad)
How major US stock indexes fared Friday 6/9/2023
Kevin O'Leary Slams Martha Stewart's Comments on Remote Work: 'Nobody Wants to Work in These Places'
66,000% upside on tiny biotech? (Ad)
MarketBeat Week in Review – 6/4 - 6/9
New Mexico reaches $500M settlement with Walgreens in opioid case
Trade Smarter: Discover Hidden Opportunities w/ A.I. (Ad)
Mark Zuckerberg Delivers Dorky Diss of Apple's Pricey New Headset
With GM and Ford embracing Tesla's EV charging technology, here's what it means for consumers
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
Laser breakthrough could send stock soaring 2,467% (Ad)
How major US stock indexes fared Friday 6/9/2023
Kevin O'Leary Slams Martha Stewart's Comments on Remote Work: 'Nobody Wants to Work in These Places'
66,000% upside on tiny biotech? (Ad)
MarketBeat Week in Review – 6/4 - 6/9
New Mexico reaches $500M settlement with Walgreens in opioid case
Trade Smarter: Discover Hidden Opportunities w/ A.I. (Ad)
Mark Zuckerberg Delivers Dorky Diss of Apple's Pricey New Headset
With GM and Ford embracing Tesla's EV charging technology, here's what it means for consumers
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
Laser breakthrough could send stock soaring 2,467% (Ad)
How major US stock indexes fared Friday 6/9/2023
Kevin O'Leary Slams Martha Stewart's Comments on Remote Work: 'Nobody Wants to Work in These Places'
66,000% upside on tiny biotech? (Ad)
MarketBeat Week in Review – 6/4 - 6/9
New Mexico reaches $500M settlement with Walgreens in opioid case
Trade Smarter: Discover Hidden Opportunities w/ A.I. (Ad)
Mark Zuckerberg Delivers Dorky Diss of Apple's Pricey New Headset
With GM and Ford embracing Tesla's EV charging technology, here's what it means for consumers
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
Laser breakthrough could send stock soaring 2,467% (Ad)
How major US stock indexes fared Friday 6/9/2023
Kevin O'Leary Slams Martha Stewart's Comments on Remote Work: 'Nobody Wants to Work in These Places'
66,000% upside on tiny biotech? (Ad)
MarketBeat Week in Review – 6/4 - 6/9
New Mexico reaches $500M settlement with Walgreens in opioid case
Trade Smarter: Discover Hidden Opportunities w/ A.I. (Ad)
Mark Zuckerberg Delivers Dorky Diss of Apple's Pricey New Headset
With GM and Ford embracing Tesla's EV charging technology, here's what it means for consumers
ETR:COP

CompuGroup Medical SE & Co. KGaA (COP) Stock Forecast, Price & News

€48.62
-0.94 (-1.90%)
(As of 06/9/2023 ET)
Compare
Today's Range
€48.40
€49.66
50-Day Range
€46.70
€51.70
52-Week Range
€30.56
€53.20
Volume
22,753 shs
Average Volume
68,245 shs
Market Capitalization
$2.54 billion
P/E Ratio
36.01
Dividend Yield
1.03%
Price Target
€57.17

COP stock logo

About CompuGroup Medical SE & Co. KGaA (ETR:COP) Stock

CompuGroup Medical SE & Co. KGaA develops and sells software and information technology solutions for the healthcare sector worldwide. The company's Ambulatory Information Systems segment develop and sell practice management software for registered physicians, medical care centers, and physician networks; and offers supplementary internet and intranet solutions. Its Pharmacy Information Systems segment develop and sell administrative and billing related software applications, which includes procuring and shipping, managing and controlling inventory, planning, performing, and monitoring retail activities for pharmacies. Hospital Information Systems segment develop and sells of clinical and administrative solutions for inpatient sector; healthcare services to acute care hospitals, rehabilitation centers, welfare institutions, multi-location hospital networks, healthcare regions, regional care organizations, medical laboratories, and radiologists. The Consumer & Health Management Information Systems segment provides software interfaces for data exchange, portals for retrieving data from the German outpatient healthcare market, medical decision support tools, medication and treatment databases for healthcare service providers, solutions for the insurance industry, and digital healthcare applications, consumer portals, and mobile apps; and operates telematics infrastructure business, which offers secure links, as well as security solutions for service providers. The company was founded in 1987 and is headquartered in Koblenz, Germany.

Receive COP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CompuGroup Medical SE & Co. KGaA and its competitors with MarketBeat's FREE daily newsletter.

COP Stock News Headlines

CompuGroup Medical SE & Co. KGaA (ETR:COP) Trading Down 0.2%
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
"Unknown laser company making HUGE profit from Russia-Ukraine War"
On February 24th, Russia invaded Ukraine. This caused major stock losses and soaring gas prices. But it also created a HUGE opportunity for savvy investors. There's an unknown laser company that's been profiting greatly from this war... ...and from another major conflict happening 3,000 miles away. Learn more here >>>
See More Headlines

COP Price History

Industry, Sector and Symbol

Industry
Health Information Services
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
8,825
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
€57.17
High Stock Price Forecast
€70.00
Low Stock Price Forecast
€36.50
Forecasted Upside/Downside
+17.6%
Consensus Rating
N/A
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Net Income
$69.58 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.21 billion
Cash Flow
€2.06 per share
Book Value
€12.99 per share

Miscellaneous

Free Float
N/A
Market Cap
$2.54 billion
Optionable
Optionable
Beta
1.06

Key Executives

  • Mr. Michael Rauch L.L.M. (Age 51)
    M.B.A., CEO, CFO, MD & Member of Management Board
    Comp: $3.34M
  • Mr. Hannes Reichl (Age 47)
    MD of Impatient & Social Care and Member of the Management Board
    Comp: $2.91M
  • Mr. Emanuele Mugnani (Age 53)
    MD of Ambulatory Information Systems Europe & Member of Management Board
    Comp: $707k
  • Dr. Eckart Pech (Age 54)
    MD of Consumer & Health Management Information Systems and Member of the Management Board
    Comp: $750k
  • Ms. Angela Mazza Teufer (Age 50)
    MD of Ambulatory Information Systems DACH, Connectivity & CLICKDOC & Member of Management Board
    Comp: $793.63k
  • Ms. Claudia Thomé (Age 52)
    Corp. VP of Investor Relations
  • Alexander Weimer
    Head of Corp. & Co-Head of Brand Communications
  • Mr. Oliver Bruzek
    Chief Communication Officer of Political & Public Affairs
  • Michael Franz
    Co- Head of Brand Communication
  • Mr. Helge Weiß
    Sr. VP of Connectivity













COP Stock - Frequently Asked Questions

What is CompuGroup Medical SE & Co. KGaA's stock price forecast for 2023?

0 equities research analysts have issued 1-year price objectives for CompuGroup Medical SE & Co. KGaA's shares. Their COP share price forecasts range from €36.50 to €70.00. On average, they predict the company's share price to reach €57.17 in the next year. This suggests a possible upside of 17.6% from the stock's current price.
View analysts price targets for COP
or view top-rated stocks among Wall Street analysts.

How have COP shares performed in 2023?

CompuGroup Medical SE & Co. KGaA's stock was trading at €35.98 on January 1st, 2023. Since then, COP shares have increased by 35.1% and is now trading at €48.62.
View the best growth stocks for 2023 here
.

Is CompuGroup Medical SE & Co. KGaA a good dividend stock?

CompuGroup Medical SE & Co. KGaA (ETR:COP) pays an annual dividend of €0.50 per share and currently has a dividend yield of 1.01%. The dividend payout ratio is 37.04%. This payout ratio is at a healthy, sustainable level, below 75%.

What other stocks do shareholders of CompuGroup Medical SE & Co. KGaA own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CompuGroup Medical SE & Co. KGaA investors own include Netflix (NFLX), Whiting Petroleum (WLL), NovelStem International (HOLL), (KOG) (KOG), Vaccinex (VCNX), Whiting USA Trust II (WHZT), Microchip Technology (MCHP), NVIDIA (NVDA), Applegreen (APGN).

What is CompuGroup Medical SE & Co. KGaA's stock symbol?

CompuGroup Medical SE & Co. KGaA trades on the ETR under the ticker symbol "COP."

What is CompuGroup Medical SE & Co. KGaA's stock price today?

One share of COP stock can currently be purchased for approximately €48.62.

How much money does CompuGroup Medical SE & Co. KGaA make?

CompuGroup Medical SE & Co. KGaA (ETR:COP) has a market capitalization of $2.54 billion and generates $1.21 billion in revenue each year. The company earns $69.58 million in net income (profit) each year or €1.35 on an earnings per share basis.

How many employees does CompuGroup Medical SE & Co. KGaA have?

The company employs 8,825 workers across the globe.

How can I contact CompuGroup Medical SE & Co. KGaA?

CompuGroup Medical SE & Co. KGaA's mailing address is Maria Trost 21, KOBLENZ, 56070, Germany. The official website for the company is www.cgm.com. The company can be reached via phone at +49-261-80000.

This page (ETR:COP) was last updated on 6/10/2023 by MarketBeat.com Staff

My Account -